Autologous serum therapy of the ocular surface with novel delivery by platelet concentrate gel.
Application of autologous serum to treat a multitude of ocular surface diseases and conditions is a relatively new technique that has gained popularity over the past 10 years. This review focuses on the use of topical autologous serum and a new platelet gel delivery technique that utilizes autologous platelet concentrate mixed with calcium chloride and thrombin for gelling serum, which can then be applied easily to the corneal surface. Residual platelet serum concentrate can be mixed with artificial tears that are capable of gelling in a 25% concentrate, which is then used by the patient postoperatively. A review of the literature identifies various concentrations of autologous serum, frequency of application, and storage criteria.
Koffler
Bruce H
BH
Department of Ophthalmology, University of Kentucky Medical Center, Lexington, KY, USA. bkoffler@kofflervisiongroup.com
D001804:Blood Transfusion, Autologous; D003316:Corneal Diseases / Q000628:therapy*; D006801:Humans; D017713:Platelet Transfusion / Q000379:methods*; D044967:Serum; D016896:Treatment Outcome